Authors

• Denise Siqueira Vanni (ORCID: https://orcid.org/0000-0002-2624-5116)
• Vlad Ratziu (ORCID: https://orcid.org/0000-0002-3051-0111)
• Michael Roden (ORCID: https://orcid.org/0000-0001-8200-6382)
• Kristiane A. Engebretsen (ORCID: https://orcid.org/0000-0003-0419-2698)
• Elisabetta Bugianesi (ORCID: https://orcid.org/0000-0002-0502-4381)
• Philip N. Newsome (ORCID: https://orcid.org/0000-0001-6085-3652)
• Arun Jayant Sanyal (ORCID: https://orcid.org/0000-0001-8682-5748)
• Iris Kliers
• Laura Østergaard
• Mary E. Rinella

Institutions

• Inserm (FR)
• King's College London (GB)
• Novo Nordisk (Denmark) (DK)
• Sorbonne Université (FR)
• University of Chicago (US)
• Düsseldorf University Hospital (DE)
• Centre de Recherche des Cordeliers (FR)
• Deutsches Diabetes-Zentrum e.V. (DE)
• King's College Hospital (GB)
• Fondation pour l’innovation en Cadiométabolisme et Nutrition (FR)
• German Center for Diabetes Research (DE)
• Heinrich Heine University Düsseldorf (DE)
• University of Turin (IT)
• University of Birmingham (GB)

Publication Details

Journal

Alimentary Pharmacology & Therapeutics

Published

2024-10-16

DOI

https://doi.org/10.1111/apt.18331

Citations

111

Primary Topic

Liver Disease Diagnosis and Treatment

Type

article

Field-Weighted Citation Impact

42.92

Funders

• Eli Lilly and Company
• Gilead Sciences
• Danone
• NGM Biopharmaceuticals
• Novo Nordisk